About this trial
Identification of exhaled breath pattern of human subjects
Eligibility criteria
This trial accepts healthy volunteersQualifiers
>= 18 years
Informed consent
Disqualifiers
specific exclusion criteria for different subgroups
Trial population
Population of human subjects with heart failure, dementia syndrome, parkinson disease, obstructive sleep apnea, chronic obstructive pulmonary disease, pneumonia, specific medication use.
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
Trial outcomes
Primary outcomes
Exhaled breath pattern
mass spectrometric profile of exhaled breath pattern of human subjects
Secondary outcomes
Chemical structure of exhaled breath molecules
The identification of the chemical structure of exhaled breath molecules
Body fluids
The correlations of identified molecules in exhaled breath with body fluids
Disease marker
The correlation of a distinct disease marker with a breath print or breath feature
Distinguish between disease
The use of a breath print to distinguish between disease and/or health state
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Zurich
Lead sponsor
Deep Breath Intelligence (DBI)
Collaborator